List of insiders holdings for ANGIODYNAMICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | EZ EM INC 10% Owner |
2004-10-12 13:17:07 | 9,200,000 0 |
9,200,000 | Form 4 |
2 | STERN HOWARD S Director 10% Owner |
2005-12-29 10:00:06 | 1,749,584 0 |
1,749,584 | Form 4 |
3 | Estate of Howard S. Stern 10% Owner |
2007-06-28 15:08:41 | 1,324,685 0 |
1,324,685 | Form 13D |
4 | Clemmer James C President and CEO |
2024-10-08 16:32:02 | 681,582 0 |
681,582 | Form 4 |
5 | Stern Linda B 10% Owner |
2008-12-23 16:03:09 | 675,812 0 |
675,812 | Form 13D |
6 | HOBBS EAMONN P President & CEO |
2009-02-17 17:50:01 | 451,651 0 |
451,651 | Form 4 |
7 | Burgstahler David F Director 10% Owner |
2017-04-14 16:48:37 | 23,988 381,406 |
405,394 | Form 4 |
8 | MEYERS DAVID P Director |
2006-08-17 09:12:40 | 390,187 0 |
390,187 | Form 4 |
9 | DEVIVO JOSEPH President and CEO |
2015-09-11 20:36:57 | 198,451 0 |
198,451 | Form 4 |
10 | Trowbridge Stephen A EVP and CFO |
2024-10-08 18:27:36 | 172,711 0 |
172,711 | Form 4 |
11 | Weiss Lawrence T SVP, Chief Legal Officer |
2024-12-04 21:33:45 | 156,347 0 |
156,347 | Form 4 |
12 | ECHENBERG PAUL S Director Emeritus |
2012-04-27 19:15:50 | 154,412 0 |
154,412 | Form 4 |
13 | DONNELLY HOWARD W Director |
2024-07-19 17:18:30 | 149,376 0 |
149,376 | Form 4 |
14 | BUCCI VINCENT Director |
2013-10-25 10:54:51 | 88,312 55,000 |
143,312 | Form 4 |
15 | Meteny Dennis S Director |
2023-07-21 21:11:16 | 140,019 0 |
140,019 | Form 4 |
16 | GRAHAM PETER J Director |
2006-10-27 10:02:48 | 62,882 66,227 |
129,109 | Form 4 |
17 | JOHNSON WESLEY Director |
2024-07-19 17:18:32 | 125,863 0 |
125,863 | Form 4 |
18 | Keltjens Jan President & CEO |
2011-01-21 12:29:25 | 109,276 0 |
109,276 | Form 4 |
19 | REED JAN STERN Director |
2024-07-19 17:18:33 | 87,359 0 |
87,359 | Form 4 |
20 | Auen Eileen O'Shea Director |
2024-07-19 17:18:24 | 87,043 0 |
87,043 | Form 4 |
21 | GOLD JEFFREY Director |
2019-07-19 21:20:00 | 83,640 0 |
83,640 | Form 4 |
22 | Gould Kevin J Director |
2020-07-16 19:06:28 | 77,504 0 |
77,504 | Form 4 |
23 | Licitra Karen A Director |
2024-07-19 17:18:25 | 72,760 0 |
72,760 | Form 4 |
24 | ROSSELL ROBERT M VP - Marketing |
2009-10-13 17:42:47 | 67,995 0 |
67,995 | Form 4 |
25 | Campbell Chad Thomas SVP/GM, Vascular Access |
2024-08-02 21:48:43 | 67,808 0 |
67,808 | Form 4 |
26 | Tarnoff Michael E Director |
2024-07-19 17:18:32 | 65,703 0 |
65,703 | Form 4 |
27 | Mitchell Robert D Executive VP and COO |
2007-08-20 19:37:54 | 63,542 0 |
63,542 | Form 4 |
28 | Centea Scott SVP/GM, VIT |
2023-09-21 21:17:23 | 62,951 0 |
62,951 | Form 4/A |
29 | FLAHERTY ROBERT E Director |
2008-08-08 16:41:29 | 50,200 0 |
50,200 | Form 4 |
30 | Wallace Lynda M. SVP - Business Development |
2010-05-19 14:52:35 | 50,000 0 |
50,000 | Form 4 |
31 | LaPorte Steve Director |
2018-07-20 21:27:34 | 48,484 0 |
48,484 | Form 4 |
32 | GERSUK D JOSEPH EVP - CFO |
2012-09-11 18:57:29 | 47,275 0 |
47,275 | Form 4 |
33 | Nighan Warren JR SVP Quality and Regulatory |
2025-01-17 16:05:54 | 41,817 0 |
41,817 | Form 4 |
34 | RECINELLA DANIEL VP - Product Development |
2007-08-20 19:33:37 | 41,174 0 |
41,174 | Form 4 |
35 | McDonald David SVP - Business Development |
2009-02-04 14:33:56 | 40,800 0 |
40,800 | Form 3 |
36 | Morris Sean SVP - General Manager |
2009-02-11 16:02:39 | 40,253 0 |
40,253 | Form 3 |
37 | Piccinini Laura SVP International |
2024-08-02 21:55:48 | 40,006 0 |
40,006 | Form 4 |
38 | Frost Mark T EVP and CFO |
2015-08-07 16:44:03 | 38,389 0 |
38,389 | Form 4 |
39 | Burgess Lorinda Director |
2024-07-19 17:18:29 | 37,582 0 |
37,582 | Form 4 |
40 | Casciaro Gregory D Director |
2006-08-17 09:11:01 | 37,500 0 |
37,500 | Form 4 |
41 | PANZER ALAN SVP, GM - Vascular |
2012-08-21 18:33:22 | 37,500 0 |
37,500 | Form 4 |
42 | KUNST BRIAN VP - Regulatory Affairs |
2007-08-20 19:29:59 | 36,780 0 |
36,780 | Form 4 |
43 | Helsel Dave SVP Global Operations and R&D |
2023-09-21 21:23:57 | 34,462 0 |
34,462 | Form 4/A |
44 | GERARDI JOSEPH G Vice President |
2007-08-20 19:26:11 | 32,992 0 |
32,992 | Form 4 |
45 | Kapusta Matthew C SVP, Business Development |
2014-11-19 16:08:25 | 30,062 0 |
30,062 | Form 4 |
46 | Simpson Robert Arthur SVP/GM, Global Vascular |
2019-08-19 22:00:02 | 25,883 0 |
25,883 | Form 4 |
47 | Bourne George W. IV CTO and COO |
2014-08-08 21:45:40 | 23,613 0 |
23,613 | Form 4 |
48 | APPLING WILLIAM M Vice-President - Research |
2010-09-07 17:56:32 | 23,386 0 |
23,386 | Form 4 |
49 | SOTO JOHN SVP and CCO |
2015-09-11 20:39:03 | 22,452 0 |
22,452 | Form 4 |
50 | Etlinger Richard Scott SVP - Global Operations |
2012-08-21 18:29:03 | 21,957 0 |
21,957 | Form 4 |
51 | Greiner Charles R VP - Global Franchise |
2016-05-09 16:05:37 | 20,910 0 |
20,910 | Form 4 |
52 | Richard Stark SVP, GM - Oncology |
2017-11-17 16:08:36 | 20,754 0 |
20,754 | Form 4 |
53 | McGill Stephen SVP, GM - International |
2014-01-30 14:01:35 | 20,715 0 |
20,715 | Form 4 |
54 | Solano Scott J. Interim CEO |
2011-08-05 20:12:46 | 19,445 0 |
19,445 | Form 4 |
55 | MAPES HAROLD VP - Operations |
2010-09-07 17:43:47 | 18,684 0 |
18,684 | Form 4 |
56 | ROSENZWEIG RICHARD C SVP and General Counsel |
2023-02-07 16:00:52 | 15,730 0 |
15,730 | Form 4 |
57 | Boucher Brent J. SVP and GM of Oncology |
2020-02-18 19:03:16 | 15,416 0 |
15,416 | Form 4 |
58 | Greiner Michael EVP and CFO |
2019-10-18 18:33:20 | 15,320 0 |
15,320 | Form 4 |
59 | Orsatti Charles Thomas Director |
2011-08-05 20:13:17 | 14,000 0 |
14,000 | Form 4 |
60 | McCarthy Shawn P SVP - General Manager |
2010-08-30 17:27:09 | 10,392 0 |
10,392 | Form 4/A |
61 | Shea Paul J VP - Sales |
2007-08-10 15:36:39 | 5,112 0 |
5,112 | Form 4 |
62 | Avista Capital Partners GP LLC Avista Capital Partners L.P. Avista Capital Partners (Offshore) L.P. Navilyst Medical Co-Invest LLC 10% Owner |
2017-04-28 17:26:56 | 0 0 |
0 | Form 13D |
63 | Venkataraman Sriram Director |
2016-08-05 16:39:03 | 0 0 |
0 | Form 4 |